Legal Representation
Attorney
Megan K. Bowen
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 2, 2014 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 1, 2014 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 16, 2014 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jan 28, 2014 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 3, 2013 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 3, 2013 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 13, 2013 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 29, 2013 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Oct 25, 2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 17, 2013 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 15, 2013 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 15, 2013 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 15, 2013 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 15, 2013 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 30, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 30, 2013 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 30, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 20, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 18, 2013 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 17, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 11, 2013 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations, namely, biologics and preparations for the treatment of hereditary disorders and conditions associated with inflammatory processes
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of an icosahedron design with the words "VIROPHARMA INCORPORATED".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"INCORPORATED"